|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Isosorbide dinitrate#Patient Counseling Information]] |
| {{Isosorbide dinitrate}}
| |
| {{CMG}}; {{AE}} {{PB}}
| |
| | |
| ==Counseling information==
| |
| | |
| Patients should be told that the [[anti-anginal]] efficacy of ISDN is strongly related to its dosing regimen, so the prescribed schedule of dosing should be followed carefully. In particular, daily headaches sometimes accompany treatment with ISDN. In patients who get these [[headache]]s, the [[headache]]s are a marker of the activity of the drug. Patients should resist the temptation to avoid headaches by altering the schedule of their treatment with ISDN, since loss of [[headache]] may be associated with simultaneous loss of [[anti-anginal]] efficacy. [[Aspirin]] and/or [[acetaminophen]], on the other hand, often successfully relieve ISDN-induced [[headaches]] with no deleterious effect on ISDN"S [[anti-anginal]] efficacy.
| |
| | |
| Treatment with ISDN may be associated with lightheadedness on standing, especially just after rising from a recumbent or seated position. This effect may be more frequent in patients who have also consumed alcohol.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISORDIL (ISOSORBIDE DINITRATE) TABLET [BTA PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abb3ad49-73a8-49c5-adc5-164d052971d7 | publisher = | date = | accessdate = 30 January 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Drugs]]
| |